Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats by Lozić, Maja et al.
                          Lozi, M., Greenwood, M., Sarenac, O., Martin, A., Hindmarch, C., Tasi, T.,
... Japundži-Žigon, N. (2014). Overexpression of oxytocin receptors in the
hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP
variability in conscious rats. British Journal of Pharmacology, 171(19), 4385-
4398. 10.1111/bph.12776
Peer reviewed version
Link to published version (if available):
10.1111/bph.12776
Link to publication record in Explore Bristol Research
PDF-document
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms.html
Take down policy
Explore Bristol Research is a digital archive and the intention is that deposited content should not be
removed. However, if you believe that this version of the work breaches copyright law please contact
open-access@bristol.ac.uk and include the following information in your message:
• Your contact details
• Bibliographic details for the item, including a URL
• An outline of the nature of the complaint
On receipt of your message the Open Access Team will immediately investigate your claim, make an
initial judgement of the validity of the claim and, where appropriate, withdraw the item in question
from public view.
1	  
	  
OVER-EXPRESSION OF OXYTOCIN RECEPTORS IN THE HYPOTHALAMIC 
PVN INCREASES BRS AND BUFFERS BP VARIABILITY IN CONSCIOUS RATS 
 
 
Maja Lozić-Đurić1, Michael Greenwood2, Olivera Šarenac1,2, Andrew Martin2, Charles 
Hindmarch2.4, Tatjana Tasić1, Julian Paton3, David Murphy2,4, Nina Japundžić-Žigon1 
 
1Institute of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine 
University of Belgrade, 11000 Belgrade, Serbia; 2Molecular Neuroendocrinology Research 
Group, The Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, 
University of Bristol, Bristol BS1 3NY, England; 3School of Physiology and Pharmacology, 
University of Bristol, Bristol, England BS8 1TD; 4Department of Physiology, University of 
Malaya, University of Malaya, Kuala Lumpur, Malaysia 50603 
 
Short title: PVN OT receptors in Autonomic Circulatory Control  
 
Corresponding author:  
 
Prof Dr Nina Japundžić-Žigon 
Institute of Clinical Pharmacology, Pharmacology and Toxicology Faculty of Medicine, 
University of Belgrade 
Dr Subotica 1 or P.O.Box 820, 11000 Belgrade, Serbia 
Tel/fax: +381 11 2685 997 
E-mail: nzigon@med.bg.ac.rs 
E-mail: nina.japundzic@gmail.com 
2	  
	  
Summary 
Background and purpose. The paraventricular nucleus (PVN) of the hypothalamus is an 
important integrative site of neuroendocrine control of the circulation. We investigated the 
role of oxytocin receptors (OTRs) in PVN in cardiovascular homeostasis. Experimental 
approach. Experiments were performed in conscious male Wistar rats equipped with 
radiotelemetric device. The PVN was unilaterally co-transfected with an adenoviral vector 
(Ad) engineered to over-express OTRs along with an enhanced green fluorescent protein 
(eGFP) tag. Control groups were PVN transfected with an Ad expressing eGFP alone or 
untransfected, sham injected wild-type rats (Wt). Rats were recorded without and with 
selective blockade of OTRs (OTX), both under baseline and stressful conditions. Baro-
receptor reflex sensitivity (BRS) and cardiovascular short-term variability were evaluated 
using the sequence method and spectral methodology, respectively. Key results. Under 
baseline conditions OTR rats exhibited enhanced BRS and reduced BP variability in 
comparison to eGFP and Wt rats. Exposure to stress increased BP, BP variability and HR in 
all rats. In eGFP and Wt rats, but not in OTR rats, BRS decreased during exposure to stress. 
Pre-treatment of OTR rats with OTX reduced BRS and enhanced BP and HR variability 
under basliene and stressful conditions. In Wt rats pre-treated with OTX, BRS was 
suppressed and BP variability was increased under baseline and stress while HR variability 
was increased only during stress. Conclusions and Implications. OTRs in PVN are involved 
in tonic neural control of BRS and cardiovascular short-term variability. The failure of this 
mechanism could critically contribute to autonomic deregulation in cardiovascular disease.  
 
Keywords.  
Oxytocin receptor, paraventricular nucleus, adenoviral vector, baro-receptor reflex, blood 
pressure variability 
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Abbreviations.  
BRR  baro-receptor reflex;  
BRS  baro-receptor reflex sensitivity;  
VLF  very low frequency short-term variability;  
LF  low frequency short-term variability;  
HF  high frequency short-term variability;  
OTRs  Oxytocin receptors 
OTX  Selective non-peptide oxytocin receptor antagonist; 
PVN  paraventricular nucleus;  
NTS  nucleus of the solitary tract; 
NA  nucleus ambiguus;  
DVN  dorsal nucleus of vagus;  
RVLM  rostroventrolateral medulla;  
IML  intermediolateral column of the spinal cord. 
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Introduction 
In addition to its well established roles in reproduction and maternity, convincing 
evidence has accumulated in the last decades to suggest that oxytocin (OT), a peptide 
hormone mainly synthesized in the hypothalamic paraventricular (PVN) and supraoptic  
nuclei, is also involved in the control of the circulation. Peripherally, an independent OT 
system has been discovered in the heart and the blood vessels, and associated with heart 
development, heart renewal and natriuresis (Gutkowska and Jankowski, 2012; Japundzic-
Zigon, 2013). OT has been shown to exert direct negative inotropic and chronotripic action 
on the heart (Costa-e-Sousa et al., 2005), to produce weak vasoconstriction (Suzuki et al., 
1992) and NO dependent vasodilatation (Katusic et al., 1986). 
In addition to its peripheral action, OT exerts endocrine and neuromodulator 
influences on the circulation (Haanwinckel et al.,1995; Randolph et al., 1998). OT neurons 
located in the parvocellular part of the PVN project to the brainstem vagal nuclear complex 
(nucleus tractus solitarius - NTS, nucleus ambiguus - NA and dorsal vagal nucleus – DVN), 
rostroventrolateral medulla (RVLM) and the intermediolateral column of the spinal cord 
(IML) where OT influences parasympathetic and sympathetic outflow to the heart and the 
blood vessels (Sawchenko and Swanson, 1982; Lang et al., 1983; Zerihun and Harris, 1983; 
Hosoya et al., 1995; Jansen et al., 1995; Hallbeck et al., 2001; Geerling et al., 2010). In vivo 
animal studies indicate that OT mediates the HR response to exercise (Martins et al., 2005) 
and HR adjustment to stress (Wsol et al., 2008). Reduction in OT mRNA in PVN and OT 
receptors mRNA in the brainstem was described in genetically hypertensive rats (Martins et 
al., 2005) while failure of central OT was associated with increased cardiovascular reactivity 
to stress in rats survivors of myocardial infarction (Wsol et al., 2009).  
OT produces its effects by the stimulation of a specific OT receptor (OTR) well 
defined in terms of genes, protein structure and pharmacology (Rozen et al., 1995, Manning 
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et al., 2012). OTRs belong to G-protein receptor family coupled to phospholipase C signaling 
pathways, and are widely distributed at the periphery and the CNS (Freund-Mercier, et al., 
1987; Gimpl and Fahrenholz, 2001). The focus of present work is the role of OTRs found in 
PVN which have been reported to play an important role in autoregulation of magnocellular 
neuronal activity (Richard et al., 1997). We hypothesized that, by increasing the number 
of OTRs located in PVN and by selectively blocking their activity, we can modulate 
PVN neuronal activity involved in autonomic cardiovascular control. To test this 
hypothesis we used genetic tools, microinjection of adenoviral vectors (Ads) carrying the 
tagged gene for OTR into the PVN to induce over-expression of OTR and 
pharmacological tools, microinjcetions of selective OTR antagonist in PVN of conscious 
transfecetd and non-transfected wild type rats, both under baseline conditions and 
stress.  
 
Methods 
All experimental procedures in this study conformed to European Communities 
Council Directive of November 24, 1986 (86/609/EEC). The experimental protocol was 
approved by the Faculty of Medicine University of Belgrade Ethics review board, and the 
results of the study are reported in accordance with The ARRIVE Guidelines. 
Animals 
Experiments were performed in male, twelve week old male Wistar rats weighing 
310-360g bred at the local animal facility. Rats were housed  individually in a controlled 
environment: 12h/12h light dark-cycle, temperature 21 ± 2 °C and humidity 60 ± 5 % with 
access to standard pelleted chows (0.2 % w/v sodium content, Veterinarski zavod, Subotica) 
and tap water ad libitum. The number of rats in each protocol was calculated statistically 
taking into account intra-group variability, using the ‘Power Sample Size Calculation’ 
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software available at: http://biostat.mc.vanderbilt.edu/twiki/bin/view/Main/PowerSampleSize  
for power of 90% and type I error probability of 0.05. At the end of the experiment, the rats 
were euthanized using a combination of three anesthetics (0.1 ml, i.p. of T61® solution). 
 
Surgery  
Rats underwent two surgical procedures at ten days interval. Under combined 
ketamine (100 mg/kg, i.m.) and xylazine (10 mg/kg, i.m.) anesthesia, a 3 cm-long medial 
abdominal incision was made and the intestine retracted to expose the abdominal aorta. The 
tip of the catheter of the radio telemetric probe (TA11-PA C40, DSI, St. Paul, MN, USA) was 
inserted into the aorta using a 21G needle. The inserted catheter was fixed with 3M 
VetbondTM and tissue cellulose patch (DSI, St. Paul, MN, USA). The transmitter was 
attached to the anterior abdominal wall and the wound was closed by suture. To prevent 
bacterial infection neomycin and bacitracin were sprayed topically, and the rats were treated 
with gentamicin (25 mg/kg i.m.) three days before, and again on the day of surgery. To 
reduce pain, rats received carprofen (5 mg/kg/day, s.c.) on the day of surgery and for the next 
two days. Each rat was housed in a Plexiglas cage (30 cm x 30 cm x 30 cm) and left to 
recover fully for 10 days.  
The second surgery was performed in wild type rats under the same anesthetics 
and postoperative care. Rats head was mounted in stereotaxic frame and the skin was 
incised 3 mm to expose the scull. A hole was opened with dental drill to position 23G 
guide above PVN (AP = 1.8 mm caudal from bregma, LAT = 0.4 mm from midline, 6.5 
mm beneath the scull; Paxinos and Watson, 2005) and fixed with dental cement. On the 
day of experimentation 7.5 mm-long 30G needle was used for microinfusion of drugs 
into the PVN. At the end of experiment, rats’ brain was removed. After the center of the 
microinfusion site was identified in the hypothalamus, the sections were dried before 
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being stained with cresyl violet acetate (0.1% w/v) and cover-slipped with DPX 
mountant (VWR). 
 
 
Adenoviral vector production 
The cDNA clone of the rat OTR in pcD2 was generously provided by Dr. Stephen 
Lolait, University of Bristol (Jeng et al., 1996). The OTR was amplified from pcD2 using 
Phusion High-Fidelity DNA polymerase (New England Biolabs) and primers OTR_F (5’-
GTCTCGAGCATGGAGGGCACGCCAGCA-3’) and OTR_R (5’-
GCCGGATCCTCATGCTGAAGATGGCTGA-3’). The PCR product was digested with 
XhoI and BamHI and ligated into compatible restriction sites of adenoviral vector 
pacAd5.CMV.IRES.GFP (Cell Biolabs). Adenoviral vector pacAd5.CMV.GFP was used as a 
control.  The adenoviruses were generated by co-transfection of viral shuttle and backbone 
(pacAd5 9.2-100) vectors in HEK293T cells by calcium phosphate method in accordance 
with manufacturer’s guidelines (Cell Biolabs). Adenoviruses were purified by two rounds of 
CsCl ultracentrifugation and desalted using Slide-A-Lyzer dialysis cassettes (Pierce). The 
purified viruses were aliquoted and stored at -80oC. The virus titers were determined in 
triplicate by standard plaque assay. 
 
Transfection 
 Ten days after fitting the telemetry device, unilateral injection of Ads into the PVN 
of rats was performed under combined ketamine xylazine anesthesia. The head of the rat was 
mounted in the stereotaxic frame and the skin was incised 3 mm to expose the scull. The 
stereotaxic coordinates of PVN (AP = 1.8 mm caudal from bregma, LAT = 0.4 mm from 
midline) were derived from the rat brain atlas (Paxinos and Watson, 2005). A glass 
micropipette was slowly positioned at 7.6 mm beneath the skull for infusion of virus (titer 
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4·1010 pfu/ml) in 50 nl pressure injected in one minute. In sham rats, a glass micropipette 
was slowly positioned at 7.6 mm beneath the skull. After removal of micropipette, the skin 
above trepanation was sutured and sprayed with antibiotics (neomycin and bacitracin). 
Immediately after transfection, a guide cannula was positioned 6.5 mm beneath the scull 
in n=6 rats, for microinfusion of OTR antagonist. In the post-operative period rats were 
treated with gentamicin (25 mg/kg i.m.) one day before, on the day of surgery and 2 days 
after surgery and carprofen (5 mg/kg/day, s.c.) on the day of surgery and two days after. Rats 
were left to recover for seven days, time necessary for maximal expression of transfected 
gene (Lonergan T et al., 2005).  
 
Evaluation of OTR expression 
Tissue preparation & collection. Brains were snap-frozen immediately aftyer sacrifice. 
Hypothalamus PVN caudal-rostral tissue sections (60µm thick), were obtained using a 
cryostat (Leica Microsystems CM1900 Cryostat) maintained between -18 ºC and -20 ºC. 
Nuclei were located via the use of Toluidine blue (0.1% in 70% EtOH) staining, using a brain 
map (Wilson & Paxinos, 2006) for reference. Bilateral tissue punches of  left and right PVN 
were taken by micro-punch (0.1mm diameter, Fine Science Tools) and stored in RNase-free 
Eppendorf tubes at -80 ºC until extraction. 
RNA extraction. Tissue samples were mechanically homogenised in 1 ml QIAzol Lysis 
Reagent (Qiagen, Cat no. 79306) and allowed to stand for 5 min at room temperature (RT) 
before centrifugation (10,300 rpm, 4 ºC) for 10min. Supernatants were collected and 
transferred into fresh eppendorf tubes. Extraction was conducted using 200µl Chloroform 
(≥99%, with amylenes as stabiliser, Sigma Aldrich) and samples were centrifuged for 15 min 
(11,200 rpm, 4 ºC), after which the aqueous phase was removed and transferred to a fresh 
Eppendorf where 1 volume (350µl) of 70% (v/v) EtOH was added to precipitate total RNA. 
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RNA purification was performed using an RNeasy Mini Kit (Qiagen, Cat No. 74104). 700µl 
(total solution) was added to RNeasy Mini Kit Spin Columns for extraction via this method. 
The RNA was eluted from the column membrane by directly adding 30µl of RNase-free 
water, after which a final 1 min spin was performed (9,600rpm, RT) to collect the RNA-
containing wash-through. Purified RNA was stored at -20 ºC until cDNA synthesis. RNA 
yield was quantified using an Implen Geneflow Nanophotometer at 390nm.  
cDNA synthesis. Using 100 ng of RNA, cDNA synthesis was carried out using a QuantiTect 
Reverse Transcription Kit (Qiagen, Cat No. 205313). cDNA samples were then diluted to a 
concentration of 2ng/uLfor use in qPCR. 
RT-qPCR plate loading & analysis.  
ANDY - needs rewriting. Need primer sequences. Need concentrations of reagents.  
What is RPL19? - define 
 
2µl of cDNA (2ng/uL) was combined with 23µl of Mastermix (for RPL19 - 12.5µl Sybr 
Green, 0.1µl Forward Primer, 0.1µl Reverse Primer, 10.3µl RNase-free water; per reaction; 
for OXT-R 2.5ul of primer (both F&R pre-mixed) used per reaction with 12.5ul Sybr Green ) 
were loaded into individual wells of a 96 well PCR plate (FrameStar PCR Plate, Rainin 
Instrument, LLC). Once loaded with all samples the plate was covered with a clear adhesive 
seal (Raining Instrument, LLC) and spun to ensure proper mixing of reagents. RT-qPCR 
analysis was then performed using an Applied Biosystems 7500 Real Time PCR System and 
Applied Biosystems 7500 SDS 1.2 software. Data generated were manually exported into a 
Microsoft Excel spreadsheet where statistical analysis was carried out. Further analysis was 
performed in Graphpad. 
10	  
	  
 
What analysis?? 
 
Pilot experiments 
Pilot experiments were performed to determine the selective dose of OTR antagonist. 
Six rats equipped with radiotelemetric device and intrahypothalamic cannula were 
used. Following vehicle application (200 nL/min 0.9% NaCl), increasing doses of 
oxytocin (30 ng, 100ng and 300 ng) in a volume of 200 nL were microinfused for 1 
minute in PVN of conscious rats, at 2 hours interval. Cardiovascular parameters were 
recorded between OT administration for 60 minutes. Five days later, non-peptide OTR 
antagonist (OTX) and OT were co-administered to rats to test OTX blocking efficacy. 
Subsequently, cardiovascular parameters were recorded for 60 minutes. 
 
Experimental design 
Seven days post-transfection, rats were subjected to experimentation. All experiments 
started around 10 a.m. in quiet surroundings under controlled environmental conditions, 
following 60-minute-long baseline recordings of rats housed individually in Plexiglas cages 
(30 cm x 30 cm x 30 cm). Cardiovascular parameters were recorded for 20 minutes under 
baseline conditions and 10 minutes during exposure of rats (n=6) to stress and during 
recovery period until normalization of BP and heart rate (HR). Stress was induced by 
directing air-jet bottle compressed under 1 bar, to the top of rats’ head. A separate 
group of wild type rats (n=6) and transfected rats (n=6) equipped with radiotelemetric 
device and intrahypothalamic cannula for drug injection, were subjected to 
microinfusion of OTX (30 ng/200 nL; n=6) or saline (200nL/min; n=6) to be recorded 
under baseline conditions for 20 minutes and 10 minutes during exposure to stress. 
11	  
	  
  
Cardiovascular signal processing and analysis 
Arterial blood pressure was digitalized at 1000 Hz in Dataquest A.R.T. 4.0 software, 
(DSI, St. Paul, MN, USA). Systolic BP (SBP), diastolic BP (DBP), mean BP (MBP) and 
pulse interval (PI) or its inverse, heart rate (HR), were derived from the arterial pulse pressure 
as maximum, minimum, integral of the arterial pulse pressure wave and inter-beat interval of 
the arterial pulse pressure wave, respectively. For each registration period mean value of 
SBP, MBP, DBP, HR and PI was calculated, and again averaged for the whole experimental 
group (values shown in tables and graphs). 
 
Evaluation of the spontaneous baro-receptor reflex by the method of sequences 
The method is explained in details elsewhere (Bajić et al., 2010). Briefly, a spontaneous 
baro-receptor reflex sequence is a stream of consecutively increasing/decreasing SBP 
samples, followed by a stream of increasing/decreasing PI interval samples delayed by 3, 4 or 
5 beats in respect to SBP. A threshold for sequence length was set to four beats (Lončar-
Turukalo et al., 2011). The sensitivity of baro-receptor reflex [BRS, ms/mmHg] was assessed 
as a linear regression coefficient averaged over all identified sequences (PI=BRS·SBP+const, 
where fitting of the curve is done in a least square sense). 
 
Spectral analysis of BP and HR 
Before spectral analysis was performed, SBP, DBP and HR signals were re-sampled 
at 20 Hz and subjected to nine-point Hanning window filter and linear trend removal 
(Milutinović et al., 2006; Stojičić et al., 2008). Spectra were obtained using a fast Fourier 
transform (FFT) algorithm on 30 overlapping 2048 point time series involving in 410-s 
registration period of SBP, DBP and HR. The power spectrum of BP (mmHg2) and HR 
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(bpm2) for 30 FFT segments was calculated for the whole spectrum (total volume, TV: 
0.019-3 Hz) and in three frequency ranges: very low frequency (VLF: 0.019-0.2 Hz), low 
frequency (LF: 0.2-0.8 Hz) and high frequency (HF: 0.8-3 Hz) range. The low frequency 
(LF) oscillation of SBP and DBP spectrum (LF-SBP and LF-DBP) and LF/HR-HR   are 
markers of sympathetic activity directed to blood vessels and sympatho-vagal balance to the 
heart, respectively (Japundzic-Žigon, 1998). 
 
Tissue preparation and immunohistochemistry 
Anesthetized rats were trans-cardially perfused with 100 ml of 0.1 M phosphate-
buffered saline (PBS pH 7.4) at room temperature followed by 300 ml of 4% (w/v) 
paraformaldehyde (PFA) in 0.1 M PBS. The brains were removed, stored and cryoprotected 
in fixative containing 20% sucrose overnight at 4°C and subsequently frozen at -80°C. 
Coronal sections (35µm) of the entire rostro-caudal axis of the forebrain were sectioned on a 
cryostat. The free-floating sections were collected in 24-well tissue culture plates containing 
PBS before being processed for immunohistochemical detection of OTRs.  
For immunohistochemical detection of OTR we used commercially available goat 
polyclonal anti-OTR antibody (1:100, Santa-Cruz, cat. nº sc-8103). Free-floating rat 
hypothalamic sections were incubated for 30 minutes in a blocking solution comprising 10% 
normal horse serum for OTR (NHS; Sigma), and 0.3% (v/v) Triton X-100 (Sigma) in 0.1 
M PBS followed by rinses (3x10min) in PBS. Sections were then incubated in goat anti-
OTR primary antibody (dilution 1:100) in PBS containing 1% (v/v) NHS and 0.3% (v/v) 
Triton X-100 overnight. After the primary antibody incubation, sections were rinsed in PBS 
(3x10min) before a 1-hr incubation in PBS containing donkey Alexa Fluor 594 anti-goat 
IgG (dilution 1:100, Abcam), 1% (v/v) NGS and 0.3% (v/v) Triton X-100 at room 
temperature. Following rinses in PBS (3x10min), and subsequent to further washes (3×10 
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min), sections were incubated for 30 minutes in 3,3’-diaminobenzidine solution, rinsed three 
times in PBS and then mounted onto glass microscope slides with 0.5% (w/v) gelatin and 
allowed to air dry for several minutes. Once dry, the slides were dehydrated in ethanol (75%, 
85%, 96% v/v), cleared in Histoclear (RA Lamb), and cover slipped in DPX mountant 
(VWR). 
 
Drugs 
Ketamine, xylazine, carprofen (Rimadyl®) and combination of embutramide plus 
mebezonium plus tetracaine (T61®) injections were purchased from Marlo Farma (Belgrade, 
RS). Gentamicin (Gentamicin®) injections and bacitracin plus neomycin spray (Bivacyn®) 
were purchased from Hemofarm (Vrsac, RS).  
 
Statistics 
 Cardiovascular parameters are presented as mean ± standard error of the mean. 
Multiple comparisons between experimental groups were performed by ANOVA for repeated 
measures followed by post hoc Bonferroni test using GraphPad Prism 4 software (GraphPad 
Software Inc., San Diego, CA, USA). Statistical significance was considered at p<0.05. 
 
Results
Verification of microinjection sites and Ad expression  
The position of the micropipette and guide cannula in the PVN at the end of each 
experiment was verified histologically (Figure 1). Ad expression was verified by analysis of 
eGFP and OTR immunohistochemistry (Figure 2).  
 
OTR qPCR?? 
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Pilot experiments 
 The dose response with OT shown in Figure 3 was performed in n=6 conscious 
Wt rats. OT microinfused into the PVN at a dose of 30 ng/200nL/min did not affect 
SBP, DBP, MBP and HR, while OT in doses of 100 ng/200nL/min and 300 
ng/200nL/min induced statistically significant and comparable increases in SBP, DBP, 
MBP and HR over the duration of 30 minutes. The hypertensive effect and tachycardia 
induced by 100 ng/200nL/min OT was prevented by pre-treatment of rats by non-
peptide and selective OTR antagonist (OTX) in a dose of 300 ng/200nL/min. OT infused 
alone in a dose of 100 ng increased SBP from 132± 2 mmHg in saline treated rats to 152 
± 1 mmHg (p<0.01) or in 300 ng OTX pretreated rats to 135 ± 4 mmHg (p<0.05). DBP 
changed from 80 ± 4 mmHg in saline treated rats to 93 ± 5 mmHg in 100 ng OT treated 
rats (p>0.01) or 73 ± 5 mmHg in OTX pre-treated rats (p<0.05) while MBP changed 
from 80 ± 4 mmHg in saline treated rats to 93 ± 5 mmHg in OT treated rats (p<0.01) to 
94 ± 2 mmHg in OTX pre-treated rats (p>0.05). HR increased from 363 ± 14 bpm to 446 
± 18 bpm in 100 ng OT treated rats (p<0.01) or to 395 ± 31 bpm in OTX pretreated rats 
(p>0.05). 
 
Cardiovascular parameters in rats over-expressing OTRs in the PVN 
Under baseline conditions and during exposure to stress mean values of SBP, MBP, 
DBP, HR and BRS did not differ between sham injected Wt and eGFP rats (table 1). In 
contrast, rats over-expressing OTRs in PVN (OTR group) exhibited increased values of SBP, 
MBP and enhanced BRS compared to eGFP and Wt controls. Exposure of rats to air-jet stress 
increased SBP, MBP, DBP and HR in all groups. In Wt and e-GFP rats, a decrease in BRS 
occurred whilst in OTR rats BRS did not decrease (table 1). 
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Spectral analysis of cardiovascular short-term variability revealed that under basal 
physiological conditions BP short-term variability was comparable between Wt and e-GFP 
rats (Figure 4). However, in OTR rats, reduction of SBP and DBP total variability due to the 
statistically significant decrease of VLF variability was observed. Concomitantly, HF-SBP 
and HF-DBP variability increased.  
When rats were exposed to air-jet stress, BP variability increased due to the increase 
of variability in all spectral bands. However, the increase of LF and HF variability in SBP 
and LF in DBP spectra was statistically significantly smaller in OTR rats as compared to both 
eGFP and Wt groups (Figure 4).  
Under baseline physiological conditions, HR variability in rats over-expressing OTRs 
in PVN did not differ from e-GFP or Wt controls (Figure 5). However, when rats were 
exposed to acute stressful conditions, OTR rats exhibited an increase of HR variability in all 
spectral bands without changes in LF to HF ratio (Figure 5) suggesting a concomitant 
sympathetic and vagal stimulation of the heart.  
 
Effect of OTX on cardiovascular parameters in Wild type rats and rats over-expressing 
OTRs in the PVN  
In wild type rats, under baseline physiological conditions, microinfusion of OTX  
into the PVN significantly reduced BRS in respect to non-treated rats, and had no effect 
on mean levels of SBP, DBP, MBP and HR (table 2). In these rats, LF-SBP LF-DBP and 
HF-SBP spectral domains increased (Figure 6). HR variability was not affected 
significantly by OTX under baseline physiological conditions (Figure 7). 
Wild type rats pre-treated by OTX and exposed to stress exhibited similar 
increase of SBP as non-treated rats, but the increase in MBP, DBP and HR were 
smaller and the BRS remained reduced (table 2). In these rats SBP and DBP variability 
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(Figure 6) and HR variability increased in all spectral domains, as well as the ratio 
LF/HF-HR (Figure 7). 
 In rats over-expressing OTR, microinfusion of OTX under baseline conditions 
reduced BRS in comparison to both non-treated OTR rats and Wt rats (table 2). OTX 
had no effect on mean values of SBP, DBP, MBP and HR of OTR rats (table 2). In these 
rats, both under baseline and stressful conditions, the increase in SBP, DBP (Figure 6) 
and HR variability (Figure 7) occurred in all spectral domains, and this was more 
pronounced than in non-transfected, wild type rats pre-treated with OTX. Also, in rats 
over-expressing OTRs in PVN and pre-treated with OTX, the increase of LF/HF-HR 
occurred both under baseline and stressful conditions (Figure 7).  
 
Discussion and Conclusions 
The finding of the present work suggest that OTRs in PVN tonically modulates 
autonomic cardiovascular control both under baseline and stressful physiological 
conditions. In wild type rats, application of OTX under baseline conditions reduced 
BPS and un-buffered BP variability. When exposed to stress, BRS remained reduced 
and HR variability increased in these rats, pointing to the domination of sympathetic 
control of the heart. In rats over-expressing OTRs, the increase in BRS was noted under 
baseline conditions and remaind increased during exposure to stress. These findings 
suggest that ectopic OTRs are functional and that the increase of their number may 
potentiate the physiological effects of naturally occurring ligand in PVN at physiological 
concentrations. Furthermore, application of OTX to OTR rats confirmed the 
functionality of ectopic OTRs, i.e. OTX reduced BRS and debuffered cardiovascular 
short-term variability under baseline and stressful conditions, and these effects were 
clearly more pronounced in OTR rats that in Wt rats.   
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It is well established that OT receptors are normally expressed in the PVN (Van 
Leeuwe et al., 1985; Freund-Mercier et al., 1987; Tribollet et al., 1988; Yoshimura et al., 
1993; Adan et al., 1995). Electrophysiological studies showed that OT receptors in the PVN 
have an important function as part of an endogenous autocontrol mechanism (Richard et al., 
1997). For instance, during suckling somato-dendritically released OT was found to stimulate 
OTRs on magnocelluar neurons in the PVN to increase the basal firing rate and establish a 
periodic bursting activity pattern. The underlying mechanisms involve priming of OT 
neurons and release of calcium from IP3-sensitive intracellular stores (Inenaga and 
Yamashita, 1986; Moos and Richard, 1989; Richard et al., 1997; Ludwig and Leng, 2006). 
Here, we provide evidence that a change of expression of OTRs in the PVN in conscious rats 
can modulate neurogenic control of the circulation. Anatomical and electrophysiological 
studies indicate that 40% of the spinally projecting PVN neurons contain mRNA for OT 
(Pyner, 2009) and that they project to NTS, DVN, NA, RVLM and IML column of the spinal 
cord (Sawchenko and Swanson, 1982; Lang et al., 1982; Zerihun and Harris, 1983; Hosoya et 
al., 1995; Jansen et al., 1995; Hallbeck et al., 2001; Geerling et al., 2010) where vagal and 
sympathetic outflow to the heart and the blood vessels is set. Functional studies by Russ and 
Walker (1994) revealed that exogenously applied OT enhances the BRS, and Higa and 
associates (2002) also reported that microinjections of OT in the NTS facilitate reflex 
bradycardia via the stimulation of OT receptors. Moreover in mice lacking OT gene and OT 
peptide, Michelini and collaborators (2003) reported blunted BRR in response to pressure 
changes. In our experiments over-expression of OTR in PVN enhanced BRS, and this 
effect on BRR was unmasked by OTX administration to wild type rats as well. Although 
our experiments cannot indicate the identity of the transmitter, there is a possibility that 
OTRs located on magnocellular neurons in the parvocellular part of PVN that project 
to cardiovascular centres in the medulla and the spinal cord could be stimulated by 
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locally (somato-dendritically) relased OT to enhance (auto-control) axonal release of 
OTX in the vicinity of NTS, where OTRs have been shown to increase BRS.  
Alternatively, over-expression of ectopic OTRs could have occurred on any other 
neuron in PVN that is integrated in neural circuitry that alter autonomic cardiovascular 
control (direct ipsilateral projections to IML, RVLM and contralateral projections to 
both) or even on astroglial cells (Doherty et al., 2011) to modulate multiple neuronal 
activity in PVN (Tasker et al., 2012). It is well established that NO, GABA and 
glutamate are crucial, while OTX, vasopressin, dopamine, angiotensin II selectively 
modulate tonic PVN signal in autonomic cardiovascular control (Pyner, 2009). All 
together, our results suggest that, in both transfected and wild type rats, OTRs in PVN 
activate downstream signaling pathways in neighboring cells leading to 
neurotransmitter release in brainstem targets that increase BRS. They also suggest that 
the number of OTRs expressed in PVN may alter the level of tonic input of PVN in 
neurogenic cardiovascular control without alteration in ligand release.  
Our results further show that up-regulation of OTRs in PVN reduces BP variability in 
the VLF frequency domain under basal physiological conditions. VLF-BP oscillations 
contribute most to overall BP short-term variability (Japundzic-Žigon, 1998), and dominate 
under basal conditions. They are created by multiple mechanisms acting in concert and 
opposition. Oscillation at ~0.1 Hz in rat originates from spontaneous myogenic activity of 
blood vessels (Stauss et al., 2009), these can be enhanced by renin-angiotensin system 
activation (Ponchon and Elhgozi, 1996) and counteracted by BRR, as suggested in 
experiments with surgical or pharmacological opening of the baro-receptor reflex loop 
(Japundzic et al., 1990; Cerutti et al., 1994). Therefore, in our experiments, the reduction of 
VLF variability could be related to enhanced BRS. Experiments with OTX revealed that 
over-expressed OTRs buffer BP and HR variability in all spectral domains under 
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baseline and stressful conditions and shift autonomic control of the heart towards the 
vagus, while the buffering effect of OTRs in PVN of wild type rats on HRV is confined 
to stress.  In this context it is important to mention that better understanding of central 
mechanisms that alter BRS, BP and HR variability that are independent prognostic markers 
of clinical outcome of cardiovascular diseases (Mancia et al., 1994; Narkiewicz and Grassi, 
2008), is of interest. 
Our experiments indicate that pharmacological effects of OT microinfused in 
PVN are hypertension and tachycardia. The failure of OTX in Wt to modulate BP and 
HR under baseline conditions indicates that OT has no tonic physiological influences on 
mean level of BP and HR. Although in OTR rats SBP and DBP are increased in respect 
to non-transfected rats, this does not seem to be directly associated with up-regulation 
of OTRs in PVN, since in OTX failed to normalize them. According to the literature, both 
hypotensive and hypertensive effects of exogenously applied OT were reported, depending 
on the route of administration. OT applied via peripheral route was found to produce short-
lasting hypertension followed by longer-lasting hypotension (Peterson et al., 1996). Centrally 
applied OT was reported to decrease BP (Peterson et al., 1996, Peterson and Uvnäs-Moberg, 
2007). It was further suggested that the central hypotensive effects of OT is mediated through 
axonal release in locus coeruleus where OT increases the density and the affinity of α-2 
adrenoceptors known to reduce sympathetic outflow (Peterson et al., 2005). In OT deficient 
mice, BP was found to be lower than in wild type mice, suggesting a tonic influence of 
endogenous OT on BP (Michelini et al., 2003). However, OT injected in RVLM or NTS or 
DVN was found to increase BP (Mack et al., 2002; Vela et al., 2010.  
It is well recognized that the PVN is a major site where integration of neuroendocrine 
and behavioural response to stress occurs (Herman and Cullinan, 1997; Dampney and 
Horiuchi 2003; Benarroch, 2005). Rats exposed to air-jet stress exhibited a startle reaction 
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followed by freezing associated with increased BP and HR. Using microdialysis Nishioka 
and co-workers (1998) found that stress increases the content of OT in PVN. It was also 
reported that specific PVN lesions, or microinjection of antagonists intracerebroventricularly 
or OT antisense oligonucleotides into the PVN (Callahan et al. 1989; 1992) attenuated the HR 
response to stress. In our experiments, microinfusion of OTX in PVN of non-transfected 
rats prevented stress-induced DBP increase and reduced tachycardia. In transfected rats 
up-regulation of OTRs in PVN did not modulate the HR response to stress, but provoked the 
increase in HR variability. The increase of HR variability occurred in both sympathetically 
and vagally mediated frequency bands. Pre-treatment of these rats with OTX in PVN 
revealed that OTRs buffer BP and HR variability and favor vagal influences to the 
heart (according to changes in LF/HF–HR ratio). This effect of OTRs in PVN on the 
heart is also seen in wild type rats only during exposure to stress (Figure 5). The increase 
of vagal influences to the heart during stress was reported to be useful in protecting the heart 
against sympathetic over-stimulation involving cholinergic NO synthesis in ventricles (Brack 
et al., 2012). This protective effect of the vagus is lifesaving during cardiac ischemia, when 
sympathetic over-stimulation triggers life threatening arrhythmias and sudden death. This 
assumption is further supported by the work of Wsol and associates (2009) who reported 
failure of brain OT to attenuate cardiovascular response to stress in rats survivors of 
myocardial infarction.  
We also observed that over-expression of OTRs in PVN buffers the stress-
induced BP variability response mediated by increased sympathetic outflow to blood 
vessels (LF) and stimulation of respiration (HF). OTX confirmed by unmasking this 
effect in both OTR over-expressing and wild type rats. The buffering effect on BP 
variability could be mediated via magnocellular neurons expressing OT and projecting to pre-
Bötzinger area (Mack et al., 2002; 2007). However we cannot rule out the possibility that 
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other neurotransmitters synthesized in PVN neurons, such as vasopressin, could have affected 
BP variability during stress Pyner (2009). Another possibility is that stress-induced axonal 
release of OT in amygdala activates a subpopulation of GABA inter-neurons that inhibit 
neurons in medial amygdala projecting to the brainstem autonomic nuclei (Huber et al., 2005; 
Viviani et al., 2011; Knobloch et al., 2012). This would attenuate the fear response, limit 
sympathetic activation and pacify respiration, as reflected in HF and LF BP short-term 
variability. Our findings are in line with a number of animal studies that suggest that OT 
activates an anti-stress response (Grippo et al., 2009; Lee et al., 2005; Windle et al., 1997; 
2004). For instance OT is found to blunt restraint-induced hypothalamo-pituitary axes 
activation (Windle et al., 1997; 2004), to decrease cardiovascular responding to isolation 
(Grippo et al., 2009), to reduce anxiety-like behavior (Windle et al., 1997) and promote social 
interactions (Lee et al., 2005). In OT knock-out mice, Bernatova and co-workers (2004) 
described accentuated BP and corticosterone response during exposure to acute stress. In line 
with their finding Wsol and colleagues (2008) reported that central application of OTR 
antagonist enhanced BP and HR increase to environmental stress. Clinical findings in humans 
also support a role for OT as an anti-stress hormone. Altemus and collaborators (2001) 
reported that lactating women have greater parasympathetic control of the heart, and Grewen 
and Light (2011) found that plasma OT in lactating women is correlated with lower 
cardiovascular reactivity to stress.  
In conclusion, our results show for the first time that OT receptors in PVN are 
involved in local (autocrine and/or paracrine) regulation of PVN neurons involved in tonic 
control of BRS and cardiovascular short-term variability. OTRs in PVN enhance the 
sensitivity of the baro-receptor reflex and buffer blood pressure and heart rate short-
term variability favoring vagal over sympathetic influences to the heart. These effects 
are more pronounced in rats over-expressing OTR in PVN than in wild type rats. Our 
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findings open new perspectives in elucidating the role of OTRs in PVN in cardiovascular 
disease and autonomic deregulations of the circulation.  
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Table 1 BP, HR and BRS in rats over-expressing OT receptors 
 
 
 SBP 
(mmHg) 
MBP  
(mmHg) 
DBP 
(mmHg) 
HR   
(bpm) 
BRS 
(ms/mmHg) 
Wt Baseline  117 ± 5 94 ± 4 82 ± 4  340 ± 12 2.3  ± 0.2  
Stress 139 ± 6 *** 120 ± 5*** 110 ± 7 *** 450 ± 21 *** 1.3 ± 0.5 * 
eGFP Baseline 118 ± 5 96 ± 4 85 ± 3  341 ± 17 2.0 ± 0.16 
Stress 138 ± 5 *** 122 ± 4*** 108 ± 3 *** 448 ± 17 *** 1.3 ± 0.4 * 
OTR Baseline 134 ± 3† ‡ ‡  106 ± 2†† ‡ ‡ 86 ± 2   351 ± 14 2.9 ± 0.3 † ‡ 
Stress 149 ± 5 ** † 115 ± 2 ** ‡ 96 ± 3 ** 430 ± 20 ** 3.4 ± 0.4 †† ‡ ‡ 
 
Values are mean of 6 rats ± s.e.m.. Wt: wild-type rats; eGFP: rats transefected with 
enhanced green fluorescent protein; OTR: rats over-expressing oxytocin receptors; SBP: 
systolic blood pressure; SBP: systolic blood pressure; MBP: mean blood pressure; DBP: 
diastolic blood pressure; HR: heart rate; BRS: baro-receptor reflex sensitivity. *p<0.05; 
**p<0.01; ***p<0.001 vs. baseline; †p<0.05; ††p<0.01 vs. eGFP-transfected rats; ‡p<0.05; 
‡‡p<0.01 vs. wild-type rats. 
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Table 2 Effects of selective OTR antagonist microinfused in PVN on BP, HR and 
BRS of Wilt type rats and rats over-expressing OT receptors  
 
 
 SBP 
(mmHg) 
MBP  
(mmHg) 
DBP 
(mmHg) 
HR   
(bpm) 
BRS 
(ms/mmHg) 
Wt Baseline  117 ± 5 94 ± 4 82 ± 4  340 ± 12 2.3  ± 0.2  
Stress 139 ± 6 *** 120 ± 5*** 110 ± 7 *** 450 ± 21 *** 1.3 ± 0.5 * 
OTXWt Baseline 123 ± 1 98 ± 2 85 ± 2  317 ± 16 1.0 ± 0.2 ‡ 
Stress 145 ± 5 *** 106 ± 3** ‡ ‡ 87 ± 2 ‡‡ 394 ± 9 ‡ ** 1.5 ± 0.2  
OTR  Baseline 134 ± 3 ‡ ‡  106 ± 2‡ ‡ 86 ± 2   351 ± 14 2.9 ± 0.3 ‡ 
Stress 149 ± 5 **  115 ± 2 ** ‡ 96 ± 3 ** 430 ± 20 ** 3.4 ± 0.4 ‡ ‡ 
OTXOTR Baseline 136 ± 5 ‡  103 ± 3‡ 87 ± 3   323 ± 12 1.2± 0.2 ‡§ § 
Stress 151 ±  6 **  111 ± 5 ** ‡  94 ± 1** ‡  414 ± 5 ** ‡ 1.7 ± 0.6 § § 
 
Values are mean of 6 rats ± s.e.m.. Wt: wild-type rats; OTXWt: Wild type rats microinfused 
with oxytocin receptor antagonist in PVN; OTR: rats over-expressing oxytocin receptors; 
OTXOTR: OTR rats microinfused with oxytocin receptor antagonist in PVN; SBP: systolic 
blood pressure; MBP: mean blood pressure; DBP: diastolic blood pressure; HR: heart rate; 
BRS: baro-receptor reflex sensitivity. *p<0.05; **p<0.01; ***p<0.001 vs. baseline; ‡p<0.05; 
‡‡p<0.01 vs. wild-type rats; §§ p<0.01 vs. OTR rats. 
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FIGURE 1 Verification of microinjection site in PVN. Representative picture. The 
arrow points to the mark made by chronic cannulation. Magnification 4 x. 
FIGURE 2  eGFP fluorescence (A), immunostaining to OTRs (B) and merged (C).  
Representative picture. Magnification 20 x. 
FIGURE 3 Effect of oxytocin microinfused in PVN on BP and HR 
 Note that 100 ng and 300 ng of OT induced comparable increase of SBP, 
MBP, DBP and HR.  
FIGURE 4 Components of BP short-term variability in rats over-expressing OTRs in 
PVN   
In OTR rats, under baseline physiological conditions a reduction of VLF-SBP 
and VLF-DBP variability and increase of HF-SBP and HF-DBP variability 
occurred. Note smaller increase of LF-SBP, LF-DBP and HF-SBP variability 
in OTR rats exposed to stress in respect to controls. Values are mean ± s.e.m.. 
Empty bars indicate baseline values, black bars indicate stress values. Wt: 
wild-type rats; eGFP: rats transefected with enhanced green fluorescent 
protein; OTR: rats over-expressing oxytocin receptors. Total-SBP: total 
systolic blood pressure variability; VLF-SBP: very low-frequency systolic 
blood pressure variability; LF-SBP: low-frequency systolic blood pressure 
variability; HF-SBP: high-frequency systolic blood pressure variability; Total-
DBP: total diastolic blood pressure variability; VLF-DBP: very low-frequency 
diastolic blood pressure variability; LF-DBP: low-frequency diastolic blood 
pressure variability; HF-DBP: high-frequency diastolic blood pressure 
variability. Values are mean of 6 rats ± s.e.m..*p<0.05; **p<0.01;***p<0.001 
vs. baseline; †p<0.05 vs. eGFP; ‡p<0.05 vs. Wt. 
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FIGURE 5 Components of HR short-term variability in rats over-expressing OTRs 
in PVN   
Note that in OTR rats HR variability was enhanced in respect to control rats 
only during stressful conditions. Empty bars indicate baseline values, black 
bars indicate stress values. Wt: wild-type rats; eGFP: rats transefected with 
enhanced green fluorescent protein; OTR: rats over-expressing oxytocin 
receptors; Total HR: total heart rate variability; VLF-HR: very low-frequency 
heart rate variability; LF-HR: low-frequency heart rate variability; HF-HR: 
high-frequency heart rate. Values are mean of 6 rats ± s.e.m.. p<0.05 vs. 
baseline; †p<0.05 vs. eGFP rats; ‡p<0.05; ‡‡p<0.01 vs. Wt. 
 
FIGURE 6 Effects of selective OTR antagonist in PVN on the components of BP 
short-term variability of Wilt type rats and rats over-expressing OT 
receptors. 
In OTR rats, under baseline physiological conditions a reduction of VLF-SBP 
and VLF-DBP variability and increase of HF-SBP and HF-DBP variability 
occurred. Also note smaller increase of LF-SBP, LF-DBP and HF-SBP 
variability in OTR rats exposed to stress in respect to controls. Empty bars 
indicate baseline values, black bars indicate stress values. Wt: wild-type rats; 
eGFP: rats transefected with enhanced green fluorescent protein; OTR: rats 
over-expressing oxytocin receptors. Total-SBP: total systolic blood pressure 
variability; VLF-SBP: very low-frequency systolic blood pressure variability; 
LF-SBP: low-frequency systolic blood pressure variability; HF-SBP: high-
frequency systolic blood pressure variability; Total-DBP: total diastolic blood 
pressure variability; VLF-DBP: very low-frequency diastolic blood pressure 
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variability; LF-DBP: low-frequency diastolic blood pressure variability; HF-
DBP: high-frequency diastolic blood pressure variability. Values are mean of 
6 rats ± s.e.m..  *p<0.05; **p<0.01;***p<0.001 vs. baseline; †p<0.05 vs. eGFP; 
‡p<0.05 vs. Wt. 
 
FIGURE 7 Effects of selective OTR antagonist in PVN on the components of HR 
short-term variability of Wild type rats and rats over-expressing OT 
receptors. 
Note that in OTR rats HR variability was enhanced in respect to control rats 
only during stressful conditions. Empty bars indicate baseline values, black 
bars indicate stress values. Wt: wild-type rats; eGFP: rats transefected with 
enhanced green fluorescent protein; OTR: rats over-expressing oxytocin 
receptors; Total HR: total heart rate variability; VLF-HR: very low-frequency 
heart rate variability; LF-HR: low-frequency heart rate variability; HF-HR: 
high-frequency heart rate. Values are mean of 6 rats ± s.e.m.. p<0.05 vs. 
baseline; †p<0.05 vs. eGFP rats; ‡p<0.05; ‡‡p<0.01 vs. Wt. 
 
